Abstract
DNA gyrases were constructed to posses the quinolone-resistant (D87N in GyrA or K447E in GyrB) and acrB (S759R-R760C in GyrB) mutations and their sensitivities to acriflavine and oxolinic acid were examined. Both quinolone- resistant mutations in GyrA and GyrB increased acriflavine sensitivities in the supercoiling assay irrespective of the co-presence of the acrB mutation. In the DNA binding assay, however, the hypersensitvity caused by the GyrB (K447E) mutation was observed only in the co-presence of the acrB mutation; the presence of the acrB mutation, which not affecting acriflavine sensitivity, reduces the extent of DNA binding, as reported previously. Thus, the quinolone-resistant mutation site in GyrB is likely to be involved in DNA binding which is not detectable in acrB+ gyrase. Furthermore, oxolinic acid was found to enhance DNA binding of the gyrase having GyrB (acrB-K447E), supporting a recent proposal that quinolone binding to the DNA-gyrase complex does not require DNA breakage.
Author supplied keywords
Cite
CITATION STYLE
Funatsuki, K., Tanaka, R., Inagaki, S., Konno, H., Katoh, K., & Nakamura, H. (1998). Quinolone-resistant mutations of DNA gyrase increase sensitivity to acriflavine. Biological and Pharmaceutical Bulletin, 21(7), 667–672. https://doi.org/10.1248/bpb.21.667
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.